GKA456V overexpression did not impact the concentration of serum lipids whereas β-hydroxybutyrate was increased, contrary to the dyslipidemia observed in GK overexpressing animals in this and earlier studies, including human carriers of the P446L GKRP mutation [14, 44]. The gene discussed is GK; the disease is metabolic syndrome.